Make data-driven decisions to improve longevity

Call9

Delivered on-demand doctors In emergency situations.

Company Information

Description

Call9 was an alternative to 911 presently operating in Skilled Nursing Facilities (nursing homes). When a nursing home patient had an acute event, instead of calling 911, SNF nurses activate Call9. Within moments Call9’s on-site Clinical Care Specialists would be at the patient’s bedside and connected, via Call9 proprietary technology, to a Board Certified Emergency Medicine Physician. Through this innovative model -- with expedited treatment as well as point of care tests (labs, EKGs, telemetry, ultrasounds, etc.) -- Call9's care helped keep patients in their nursing home bed in more than 80% of activations; saving the healthcare system, and the taxpayer, millions of dollars.

Legal Name

Former Legal Name(s)

Company Reputation

Entity Type

Private limited company

Ownership Status

Operational Status

Inactive

Founded Date

1 Jan 2015

Operational Duration

4 years

Shutdown Date

2019

Last Financing Round

Series B

Total Raised

USD 34M

Last Financing Date

14 Sep 2017

No. of Funding Round(s)

No. of Investor(s)

No. of Employees

100 - 250

Total Revenue

Post-money Valuation

Market Capitalization

Stage of Development

Validation

Transactional Model Type

B2C

Defensibility Moats

Business model innovation,

City

Brooklyn

State/Province

New York

Country

United States

Industry

Technology

Categories

On-Demand Service, Consumer Services, Health, Health Care Technology,

Product Gallery

Direct Competitors and Similar Companies

Note: Direct competitors are defined by similarity score of more than 40%, while similar companies are defined by similarity score of less than 40%

No.	Image	Name	Similarity score	Description	Industry	Categories	Location	Ownership status	Entity type	Stage of development	Transactional model type	Defensibility moats	Last financing round	Total raised	Post-money valuation	Last financing date	No. of funding round(s)	No. of investors	Investors	Total revenue	Market capitalization	No. of investments	No. of acquisitions	No. of board seats taken	Competition	Management	No. of employees	Company reputation	Contact info	Operational status	Operational duration	Shutdown date	Founded date	Legal name	Former legal name(s)	Ticker
1.		Zeo	14.7%	Manufactured sleep monitors that recorded electrical activity.	Technology	Electronics, Electronics, Lifestyle, Health	United States	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10-50	-	-	Inactive	-	-	2003	-	-	-

Investors

No.	Name	Investor type	Description	Location	Preferred investment stage(s)	Stages invested in	Assets under management (AUM)	Investment range	Investment sweet spot	Preferred investment focus	Preferred investment geography	No. of investments	No. of lead investments	No. of follow-on investments	No. of co-investments	Portfolio companies	No. of exits	Total exit value	No. of failed investments	Loss on investments	No. of acquisitions	No. of board seats taken	No. of funds	Limited partners	Co-investors	No. of partners	Partners	No. of employees	Management	Board members	Founders	Investor reputation	Contact info	Entity type	Legal name	Former legal name(s)	Founded date	Ticker
1.	8VC	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
2.	Anne Wojcicki	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
3.	Great Oaks Venture Capital	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
4.	Index Ventures	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
5.	Moment Ventures	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
6.	Refactor Capital	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
7.	Y Combinator	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Leadership

No.	Name	Previous designation	Previous company	Previous biography	Previous profile type	Previous location	Experience	Education	Reputation	Current company	Current designation	Current biography	Current profile type	Current location	No. of investments	No. of exits	Total exit value	No. of board seats taken	Contact info
1.	Celina Tenev	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
2.	Timothy Peck	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
3.	XiaSong Mu	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Funding

No.	Financing date	Financing round	Total amount raised	Post-money valuation	Financial viability	Fundraising target amount	Remaining target amount	Financing type	No. of investors	Board seats	Lead investors	Entity type	Financing status
1.	14 Sep 2017	Series B	USD 24M	-	-			-	6	-	-	-	Completed
2.	14 Jan 2016	Series A	USD 10M	-	-			-	7	-	-	-	Completed
3.	18 Aug 2015	Funding round	-	-	-	-	-	-	2	-	-	-	-